

Cover Story
Free
By Matthew Bin Han Ong
The Blue Ribbon Panel—a group of experts selected to identify scientific opportunities for the National Cancer Moonshot Initiative—has submitted 10 recommendations to the National Cancer Advisory Board.
By Laura Brawley
In Brief


Drugs & Targets


Trending Stories
- Mikaela Naylon Give Kids a Chance Act nixed by Senate
- Antonio Wolff, Mikala Egeblad named co-directors of Johns Hopkins Kimmel Cancer Center Breast and Gynecologic Cancer Program
- Twitter star Vinay Prasad retires @VinayPrasadMD
- Otis Brawley looks back on a year of great science and greater challenges
- A farewell post by an unidentified NCI employee triggers an accusation of “undermining the Trump administration”
- Dana-Farber to pay $15M to U.S. government in research fraud settlement













